In conclusion, transplantation of NILB-hiPSCs could effectively alleviate TDP-43-mediated neuropathology, including increased gliosis and cytoplasmic mislocalization of TDP-43, making it a potential treatment for different types of neurodegenerative diseases. The gene discussed is TARDBP; the disease is neurodegenerative disease.